A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma

Thomas, Melanie B.; Garrett-Mayer, Elizabeth; Anis, Munazza; Anderton, Kate; Bentz, Tricia; Edwards, Andie; Brisendine, Alan; Weiss, Geoffrey; Siegel, Abby B.; Bendell, Johanna; Baron, Ari; Duddalwar, Vinay; El-Khoueiry, Anthony

期刊名称Oncology
作者Thomas, Melanie B.; Garrett-Mayer, Elizabeth; Anis, Munazza; Anderton, Kate; Bentz, Tricia; Edwards, Andie; Brisendine, Alan; Weiss, Geoffrey; Siegel, Abby B.; Bendell, Johanna; Baron, Ari; Duddalwar, Vinay; El-Khoueiry, Anthony
卷第94卷
期第6期
印刷ISSN0030-2414
电子ISSN1423-0232
文件大小395.69KB
发表时间2018
DOI10.1159/000485384
页码329-339

发现好书期刊，享受阅读乐趣

A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma